Latest News

Vitamin D deficiency linked to psoriasis severity


 

FROM NUTRITION 2023

Investigators have found a correlation between vitamin D deficiency and psoriasis severity, suggesting that some people who increase their intake of the vitamin could better control this skin condition that affects up to 8 million people in the United States alone.

Brown University researchers studied almost 500 psoriasis cases taken from the National Health and Nutrition Examination Survey (NHANES), the scientists told attendees at the conference of the American Society for Nutrition. They compared the peoples’ reports on how much of their body surface was affected by psoriasis to vitamin D levels collected in blood samples.

“After adjusting for lifestyle factors such as smoking, the analysis showed that lower vitamin D levels and vitamin D deficiency were significantly associated with greater psoriasis severity,” the ASN said in a news release. “The researchers also found that patients with the least amount of body surface affected by psoriasis had the highest average vitamin D levels while those with the greatest affected area had the lowest average levels of vitamin D.”

The researchers said that people with psoriasis might improve their condition by getting more vitamin D in their diet and through supplements.

“Topical synthetic vitamin D creams are emerging as new therapies for psoriasis, but these usually require a doctor’s prescription,” said researcher Rachel K. Lim, an MD candidate at Brown University, Providence, R.I. “Our results suggest that a vitamin D–rich diet or oral vitamin D supplementation may also provide some benefit to psoriasis patients.”

The researchers said that vitamin D toxicity is rare but that people should consult with their medical caregivers before they start taking supplements.

A version of this article first appeared on WebMD.com.

Recommended Reading

Cell activity in psoriasis may predict disease severity and provide clues to comorbidities
MDedge Rheumatology
After Yusimry’s steep discount, little clarity on future adalimumab biosimilar pricing
MDedge Rheumatology
Methotrexate does not impair sperm quality, small study finds
MDedge Rheumatology
Does colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?
MDedge Rheumatology
For psoriasis, review finds several biosimilars as safe and effective as biologics
MDedge Rheumatology
New guidelines for MTX use in pediatric inflammatory skin disease unveiled
MDedge Rheumatology
Oral IL-23 receptor antagonist for psoriasis promising: Phase 2b study
MDedge Rheumatology
Keep depression, anxiety screening top of mind in patients with psoriatic disease
MDedge Rheumatology
Remote teams offer chance to improve difficult-to-treat PsA
MDedge Rheumatology
Humira biosimilars: Five things to know
MDedge Rheumatology